Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomas

Radiation Oncology

Stephanie E Combs³  Jürgen Debus³  Klaus Herfarth³  Oliver Jäkel²  Stefan Rieken³  Daniel Habermehl³  Swantje Ecker¹  Katsura Kosaki³ 

[1] Heidelberg Ion Therapy Center (HIT), Heidelberg, Germany;Department of Medical Physics, German Cancer Research Center (dkfz), Heidelberg, Germany;Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany

关键词: Gantry;    Protons;    Carbon ions;    Photon IMRT;    Plan comparison;   

Others  :  1160872
DOI  :  10.1186/1748-717X-7-44

 received in 2011-12-25, accepted in 2012-03-22,  发布年份 2012

【 摘 要 】

Background

To examine the potential improvement in treatment planning for patients with skull base meningioma using IMRT compared to carbon ion or proton beams with and without a gantry.

Methods

Five patients originally treated with photon IMRT were selected for the study. Ion beams were chosen using a horizontal beam or an ion gantry. Intensity controlled raster scanning and the intensity modulated particle therapy mode were used for plan optimization. The evaluation included analysis of dose-volume histograms of the target volumes and organs at risk.

Results

In comparison with carbon and proton beams only with horizontal beams, carbon ion treatment plans could spare the OARs more and concentrated on the target volumes more than proton and photon IMRT treatment plans. Using only a horizontal fixed beam, satisfactory plans could be achieved for skull base tumors.

Conclusion

The results of the case studies showed that using IMPT has the potential to overcome the lack of a gantry for skull base tumors. Carbon ion plans offered slightly better dose distributions than proton plans, but the differences were not clinically significant with established dose prescription concepts.

【 授权许可】

   
2012 Kosaki et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Islam MA, Yanagi T, Mizoe J, Mizuno H, Tsujii H: Comparative study of dose distribution between carbon ion radiotherapy and photon radiotherapy for head and neck tumor. Radiat Med 2008, 26:415-421.
• [2]Lomax AJ, Goitein M, Adams J: Intensity modulation in radiotherapy: photons versus protons in the paranasal sinus. Radiother Oncol 2003, 66:11-18.
• [3]Mock U, Georg D, Bogner J, Auberger T, Pötter R: Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys 2004, 58:147-154.
• [4]Cozzi L, Fogliata A, Lomax A, Bolsi A: A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours. Radiother Oncol 2001, 61:287-297.
• [5]Baumert BG, Lomax AJ, Miltchev V, Davis JB: A compariosn of dose distributions of proton and photon beams in stereotactic conformal radiotherapy of brain lesions. Int J Radiat Oncol Biol Phys 2001, 49:1439-1449.
• [6]Cozzi L, Clivio A, Vanetti E, Nicolini G, Fogliata A: Comparative planning study for proton radiotherapy of benign brain tumors. Strahlenther Onkol 2006, 182:376-81.
• [7]Fuss M, Hug EB, Schaefer RA, et al.: Proton radiation therapy (PRT) for pedoatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique. Int J Radiat Oncol Biol Phys 1999, 45:1117-1126.
• [8]Bolsi A, Fogliata A, Cozzi L: Radiotherapy of small intracranial tumours with different advanced techniques using photon and proton beams: a treatment planning study. Radiother Oncol 2003, 68:1-14.
• [9]Hug EB, Devries A, Thornton AF, et al.: Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol 2000, 48:151-160.
• [10]Wenkel E, Thornton AF, Finkelstein D, et al.: Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys 2000, 48:1363-70.
• [11]Boskos C, Feuvret L, Noel G, et al.: Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. Int J Radiat Oncol Biol Phys 2009, 75:399-406.
• [12]Noel G, Bollet MA, Calugaru V, et al.: Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons. Int J Radiat Oncol Biol Phys 2005, 62:1412-1422.
• [13]Jäkel O, Debus J: Selection of beam angles for radiotherapy of skull base tumours using charged particles. Phys Med Biol 2000, 45:1229-41.
• [14]Suit H, DeLaney T, Goldberg S, et al.: Proton vs carbon ion beams in the definitive radiation treatment of cancer patients. Radiother Oncol 2010, 95:3-22.
• [15]Combs SE, Bischof M, Welzel T, et al.: Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas. J Neurooncol 2008, 89:205-10.
• [16]Debus J, Wuendrich M, Pirzkall A, et al.: High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term-results. J Clin Oncol 2001, 19:3547-53.
• [17]Emami B, Lyman J, Brown A, et al.: Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-22.
• [18]Vernimmen FJ, Harris JK, Wilson JA, Melvill R, Smit BJ, Slabbert JP: Stereotactic proton beam therapy of skull base meningiomas. Int J Radiat Oncol Biol Phys 2001, 49:99-105.
• [19]Gudjonsson O, Blomquist E, Nyberg G, et al.: Stereotactic irradiation of skull base meningiomas with high energy protons. Acta Neurochir (Wien) 1999, 141:933-940.
• [20]Combs SE, Hartmann C, Nikoghosyan A, et al.: Carbon ion radiation therapy for high-risk meningioma. Radiother Oncol 2010, 95:54-59.
• [21]Glaholm J, Bloom HJ, Crow JH: The role of radiotherapy in the managemant of intracranial meningiomas: The Royal Marsden Hospital experience with 186 patients. Int J Radiat Oncol Biol Phys 1990, 18:755-761.
• [22]Cusimano MD, Sekhar LN, Sen CN, et al.: The results of surgery for benign tumors of the cavernous sinus. Neurosurgery 1995, 37:1-9.
• [23]De Jesus O, Sekhar LN, Parikh HK, Wright DC, Wagner DP: Long-term follow-up of patients with meningiomas involving the cavernous sinus: Recurrence, progression, and quality of life. Neurosurgery 1996, 39:915-919.
• [24]DeMonte F, Smith HK, al Mefty O: Outcome of aggressive removal of cavernous sinus meningiomas. J Neurosurg 1994, 81:245-251.
• [25]Goel A, Muzumdar D, Desai KI: Tuberculum sellae meningioma: A report on management on the basis of a surgical experience with 70 patients. Neurosurgery 2002, 51:1358-1363.
• [26]Newman SA: Meningiomas: A quest for the optimum therapy. J Neurosurg 1994, 80:191-194.
• [27]Noel G, Habrand JL, Mammar H, et al.: Highly conformal therapy using proton component in the management of meningiomas. Preliminary experience of the Centre de Proton-therapie d'Orsay. Strahlenther Onkol 2002, 178:480-485.
• [28]Weber DC, Lomax AJ, Rutz HP, et al.: Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas. Radiother Oncol 2004, 71:251-258.
• [29]Wilkins JJ, Oelfke U: Direct comparison of biologically optimized spread-out bragg peaks for protons and carbon ions. Int J Radiat Oncol Biol Phys 2008, 70:262-266.
• [30]Mizumoto M, Nakayama H, Tokita M, et al.: Technical considerations for noncoplanar proton-beam therapy of patients with tumors proximal to the optic nerve. Strahlenther Onkol 2010, 186:36-39.
• [31]Schulz-Ertner D, Tsujii H: Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 2007, 25:953-64.
• [32]Combs SE, Nikoghosyan A, Jaekel O, et al.: Carbon ion radiotherapy for pediatric patients and young adults treated for tumors of the skull base. Cancer 2009, 115:1348-1354.